In the August 18, 2015, Federal Register, FDA's Center for Biologics Evaluation and Research ("CBER") and CDER announced their support for the 3.2 version of Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model Implementation Guide. FDA is encouraging sponsors to use this guide in investigational study data provided in regulatory submissions to CBER and CDER.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
